Overview

A Study to Evaluate Food Effect on ONO-5920/YM529 Intermittent Formulation

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the effects of food intake on the plasma concentration profile of YNO-5920/YM529 in post menopausal women.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Collaborator:
Ono Pharma USA Inc
Treatments:
Diphosphonates